AMPEL BioSolutions Focused on Developing Clinical Blood Test Predicts the Correct Drug for a Patient

Date: February 11, 2022

AMPEL BioSolutions COO Dr Amrie Grammer chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Charlottesville, Virginia-based company can identify drugs for treating lupus patients. According to its website, the company’s system can be applied to any disease.

Pin It on Pinterest